Case Investigations

Patriot National, Inc.

March 24, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Patriot National, Inc. (“Patriot National” or the “Company”) (NYSE: PN).  Investors who purchased Patriot National securities between August 15, 2016 and March 3, 2017, inclusive (the “Class Period”), have until May 15, 2017 to file lead plaintiff applications in a securities class action filed in the United States District Court for the Southern District of New York.

AmTrust Financial Services, Inc.

March 17, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of AmTrust Financial Services, Inc. (“AmTrust” or the “Company”) (NASDAQ: AFSI).  Investors who purchased shares of AmTrust securities may be affected.

Netflix, Inc.

March 15, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Netflix, Inc. (“Netflix” or the “Company”) (NASDAQ:  NFLX).

Pearson, plc.

March 7, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Pearson, plc. (“Pearson” or the “Company”) (NYSE:  PSO).

Invuity, Inc.

March 7, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Invuity, Inc. (“Invuity” or the “Company”) (NASDAQ:  IVTY).

Galena Biopharma, Inc.

February 22, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Galena Biopharma, Inc. (“Galena” or the “Company”) (NASDAQ:  GALE).

The Western Union Company

February 13, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Western Union Company (“Western Union” or the “Company”) (NYSE: WU).

Vista Outdoor Inc.

February 10, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Vista Outdoor Inc. (“Vista Outdoor” or the “Company”) (NYSE: VSTO).

ReWalk Robotics Ltd.

January 31, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (NYSE: RWLK).

NCI, Inc.

January 23, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of NCI, Inc. (“NCI” or the “Company”) (NASDAQ: NCIT).  Investors who purchased shares of NCI common stock prior to January 23, 2017 may be affected.

Banc of California, Inc.

January 23, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Banc of California, Inc. (“Banc of California” or the “Company”) (NYSE: BANC).  Investors who purchased shares of Banc of California common stock prior to January 23, 2017 may be affected.

Gigamon, Inc.

January 19, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Gigamon, Inc. (“Gigamon” or the “Company”) (NYSE: GMO). Investors who purchased shares of Gigamon common stock during the period October 28, 2016 through January 17, 2017 may be affected.

DaVita, Inc.

January 10, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating DaVita Inc. ("DaVita” or the "Company") (NYSE: DVA) for potential violations of the federal securities laws.  Investors who purchased DaVita common stock may be affected.

Inovalon Holdings, Inc.

December 13, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Inovalon Holdings, Inc. ("Inovalon” or the "Company") (NASDAQ: INOV) for potential violations of the federal securities laws.  Investors who purchased Inovalon securities may be affected.

Trinity Biotech plc

October 19, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Trinity Biotech plc. ("Trinity” or the "Company") (NASDAQ: TRIB), a company developing medical diagnostics products, for potential violations of the federal securities laws.  Investors who purchased Trinity’s American Depositary Receipts (“ADRs”) between December 17, 2015 and October 3, 2016 may be affected.

Opus Bank

October 19, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Opus Bank (“Opus”) (NASDAQ: OPB) for potential violations of the federal securities laws.  Investors who purchased Opus Bank securities between February 26, 2015 and October 18, 2016 (the “Class Period”) may be affected.

Ferrellgas Partners, L.P.

October 11, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Ferrellgas Partners, L.P. ("Ferrellgas” or the "Company") (NYSE: FGP) for potential violations of the federal securities laws.  Investors who purchased Ferrellgas securities between June 1, 2015 and September 28, 2016 (the “Class Period”) may be affected.

Centene Corp.

August 31, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Centene Corp. (“Centene” or the "Company") (NYSE: CNC).  Investors who purchased Centene securities between June 17, 2016 and July 25, 2016 may be affected.

Immunomedics, Inc.

June 3, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Immunomedics, Inc. (“Immunomedics” or the “Company”) (Nasdaq: (IMMU).  Investors who purchased Immunomedics securities between May 4, 2016 and June 2, 2016 may be affected.

Credit Acceptance Corporation

May 4, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Credit Acceptance Corporation ("Credit Acceptance” or the "Company") (NASDAQ: CACC), a subprime auto lender, for potential violations of the federal securities laws.  Investors who purchased shares of Credit Acceptance common stock may be affected.

Natus Medical Incorporated

April 10, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Natus Medical Incorporated (“Natus” or the "Company") (Nasdaq: BABY).  Investors who purchased Natus securities between October 15, 2015 and April 1, 2016 may be affected.

LPL Financial Holdings Inc.

March 30, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating LPL Financial Holdings Inc. (“LPL” or the “Company”) on behalf of investors who purchased LPL securities between December 8, 2015 and February 11, 2016.

GAIN Capital Holdings, Inc.

March 16, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating GAIN Capital Holdings, Inc. (“Gain” or the "Company") (NYSE: GCAP).  Investors who purchased Gain securities between February 27, 2014 and March 15, 2016 may be affected.

Aequitas Management LLC

March 10, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Oregon-based Aequitas Management LLC (“Aequitas” or the "Company").  On March 10, 2016, the U.S. Securities and Exchange Commission (“SEC”) charged Aequitas and three senior executives “with hiding the rapidly deteriorating financial condition of its enterprise while raising more than $350 million from investors."

Match Group, Inc.

February 3, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Match Group, Inc. (“Match” or the “Company”) (Nasdaq: MTCH) for potential violations of the federal securities laws.  Investors who purchased the Company’s common stock since the Company’s initial public offering of common stock on November 18, 2015 at $12 per share on may be affected.

Cnova NV

January 25, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Cnova NV ("Cnova” or the "Company") (Nasdaq: CNV) for potential violations of the federal securities laws.  Investors who purchased Cnova securities may be affected.

Fifth Street Asset Management, Inc.

January 12, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Fifth Street Asset Management, Inc. (“FSAM” or the “Company”) (NASDAQ: FSAM).  FSAM is a credit-focused asset manager and the investment advisor for Fifth Street Finance Corp. (“FSC”), Fifth Street Senior Floating Rate Corp. (“FSFR”), and various private Fifth Street funds. Investors who purchased shares of FSAM common stock in the Company’s October 29, 2014 initial public offering (“IPO”) or since the IPO may be affected.

Anavex Life Sciences Corporation

December 29, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Anavex Life Sciences Corporation (“Anavex” or the “Company”) (Nasdaq: AVXL) for potential violations of the federal securities laws.  Investors who purchased Company securities between October 25, 2015 and December 28, 2015 may be affected.

KaloBios Pharmaceuticals, Inc.

December 21, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating KaloBios Pharmaceuticals, Inc. ("KaloBios” or the “Company”) (NASDAQ: KBIO) for potential violations of the federal securities laws.  Investors who purchased KaloBios’ common stock may be affected.

Neothetics, Inc.

December 15, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Neothetics, Inc. (“Neothetics” or the “Company”) (NASDAQ: NEOT).  Neothetics is a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market. The Company’s lead product candidate, LIPO-202, is for the reduction of subcutaneous fat in the central abdomen (belly fat) in non-obese patients.  Investors who purchased shares of Neothetics common stock in the Company’s initial public offering (“IPO”) or since the IPO may be affected.